What you'll learn
Identify current and emerging approaches to early detection, screening, and prevention of hereditary breast, ovarian, pancreatic, and prostate cancers associated with mutations in the BRCA pathway.
Recognize and analyze the latest clinical and translational discoveries in the treatment of breast, ovarian, pancreatic, and prostate cancers associated with hereditary or acquired mutations in BRCA1/2 and related genes.
Discuss current ethical, legal, social as well as diversity and inclusion issues related to carriers of BRCA1/2 and related genes.
Course description
Who Should Attend
- Specialty Physicians
- Researchers
- Clinicians
- Other
You may also like
Blended
Price
$17,900 - $18,900
Registration Deadline
Starts Apr 8
Online Live
Price
$325 - $425
Registration Deadline
Starts Sep 18